Drug Shortage Report for LUPIN-CEPHALEXIN

Last updated on 2021-02-13 History
Report ID 127186
Drug Identification Number 02469170
Brand name LUPIN-CEPHALEXIN
Common or Proper name LUPIN-CEPHALEXIN
Company Name LUPIN PHARMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) CEPHALEXIN
Strength(s) 125MG
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 100 and 150 ML
ATC code J01DB
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2020-11-06
Estimated end date 2021-02-12
Actual end date 2021-02-12
Shortage status Resolved
Updated date 2021-02-13
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 550-1111 RUE ST-CHARLES OUEST
LONGUEUIL, QUEBEC
CANADA J4K 5G4
Company contact information lupin@lsu3pl.ca (Customer service / Service à la clientèle)

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2021-02-13 English Compare
v12 2021-02-10 French Compare
v11 2021-02-10 English Compare
v10 2021-02-10 English Compare
v9 2021-01-30 French Compare
v8 2021-01-30 English Compare
v7 2021-01-04 French Compare
v6 2021-01-04 English Compare
v5 2020-11-07 English Compare
v4 2020-11-06 French Compare
v3 2020-11-06 English Compare
v2 2020-10-26 French Compare
v1 2020-10-26 English Compare

Showing 1 to 13 of 13